Arcus Biosciences to Participate in Upcoming August Investor Conferences

On July 28, 2020 Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, reported that management will present at the following upcoming virtual investor conferences (Press release, Arcus Biosciences, JUL 28, 2020, View Source [SID1234562471]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG Virtual Biotechnology Conference 2020, Monday, August 10 at 11:00 am ET
2020 Wedbush PacGrow Healthcare Virtual Conference, Tuesday, August 11 at 1:45 pm ET
A live audio webcast of each presentation will be available by visiting the "Investors" section of the Arcus website at www.arcusbio.com. A replay of the webcasts will be available for at least two weeks following the live event.